Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seropersistence and Booster Response of FSME-IMMUN in Adults
NCT00161785Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2004
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Pfizer. Started Jun 2004; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00161785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161785.